ambossIconambossIcon

Poisoning

Last updated: October 17, 2024

Summarytoggle arrow icon

Poisoning describes the harmful effects of exposure (i.e., inhalation, ingestion, injection, absorption) to a potentially toxic substance. The degree of harm depends on substance factors (e.g., type, amount, route of exposure) and patient factors, (e.g., age, body habitus, organ function). Poisoning is typically managed in consultation with a medical toxicologist and/or a local poison control center and can involve acute stabilization, supportive care, decontamination, enhanced elimination, and antidotes. The type and urgency of management depend on each individual's toxicological risk assessment, which is primarily based on the toxicological history and physical examination, and supported diagnostics tests. In the US, the Poison Help line (1-800-222-1222) allows for immediate 24/7 specialist consultation nationwide.

This article is an overview of poisoning with details on cyanide, cleaning products (e.g., caustic agents), mushrooms, plants, and rodenticides. Details on other poisonings are covered in their respective articles.

For a clinical approach and details on management common to all poisoning, see “Approach to the poisoned patient.”

Overviewtoggle arrow icon

Overview of poisonings and their management

Overview of poisoning and management
Substance Pathophysiology Management
Anticholinergics [1]

Cholinergics [2]

CNS stimulants [2]

Barbiturates [2]
Benzodiazepines [2]
Opioids [3][4]
Beta blockers [2][4]
Digitalis [4]
Warfarin [5]
Dabigatran [5][6]
Heparin [4][7]
Fibrinolytics [8]
Salicylates [4]
Acetaminophen [4]
Tricyclic antidepressants [2][9]
Methanol or ethylene glycol [4][10]

Metals [11][12][13][14]

  • Varies by metal
Carbon monoxide [4][15]
Cyanide [16]
Substances that cause acquired methemoglobinemia [4][17]

Activated charcoal effectively binds acetaminophen, aspirin, and tricyclic antidepressants.

Activated charcoal is ineffective in GI decontamination of heavy metal poisoning, cyanide poisoning, lithium poisoning, caustic ingestions, and toxic alcohol poisoning.

Toxidromes

Drug-related

Environmental substance-related

Cyanidestoggle arrow icon

Description

Cyanide is highly toxic and rapidly lethal; exposure to small amounts can be fatal. [18]

Sources of exposure [16]

  • Fires: Cyanide is released by various substances during combustion (e.g., plastics, upholstery, rubber).
  • Industrial: metal industry, electroplating, manufacture of nitrogen-containing materials and products (e.g., plastics, jewelry)
  • Medical: long-term or high-dose treatment with sodium nitroprusside, especially in patients with CKD
  • Biological: : naturally occurring substances containing cyanogenic compounds (e.g., amygdalin), including cassava, apricot seeds, and bitter almonds

Pathophysiology [4][16]

Clinical features [16][19]

Consider cyanide poisoning in patients who develop symptoms after treatment with sodium nitroprusside (e.g., for hypertensive emergency).

Diagnostics [4][20]

Cyanide poisoning is primarily a clinical diagnosis. [20]

MRI brain is typically normal in cyanide poisoning, whereas carbon monoxide poisoning is generally associated with globus pallidus hypodensities.

Management [4][16]

Do not delay empiric antidotal treatment if cyanide poisoning is suspected. [4]

Antidotes for cyanide poisoning [4][16]

Indications

Hydroxocobalamin

Hydroxocobalamin may cause red discoloration of the patient's skin, urine, and plasma, which can affect the accuracy of laboratory studies that rely on spectrophotometry (e.g., CO-oximetry, lactate levels). [4]

Nitrites

Exercise caution in patients with suspected carbon monoxide poisoning as inducing methemoglobinemia can worsen tissue hypoxia. [21]

Sodium thiosulfate

Cleaning productstoggle arrow icon

Toxic substances [2][22][23][24][25]

  • Household and industrial cleaning products may contain multiple substances of varying toxicity.
  • Tissue corrosion is the most common and clinically important effect.

Caustic agents

Noncaustic detergents and disinfectants [24]

  • Active ingredients have milder corrosive, irritant, or otherwise toxic effects than caustic agents, e.g.:
  • Effects are usually mild but may occasionally cause significant toxicity. [24]
  • Examples: laundry detergents, dishwasher tablets, dish soaps, hand soaps, single-use pods, household disinfectants

Caustic agents and other toxic substances may be present in some, but not all, household dishwashing and laundry detergents.

Ingestion

Clinical features [25]

Management [4][25][26]

Do not induce vomiting, as this can cause further damage to the esophagus. Do not attempt to neutralize an alkali with a weak acid, as this can lead to vomiting or local heat production. [4][25]

Disposition [4][25][26]

  • Most patients with caustic ingestion require admission.
  • Potential airway compromise, significant injury, or suspected GI perforation: Urgent surgery and/or ICU admission are typically required.
  • Asymptomatic or minimally symptomatic patients
    • Consider an observation unit or inpatient admission for continued monitoring.
    • If EGD is performed in the ED, determine disposition based on specialist recommendations.

Complications

Ocular exposure [4]

Injuries caused by ocular exposure vary and can range from corneal abrasion and irritation to ocular chemical burns. [27]

Skin exposure [4][26]

Clinical features

Management

Mushroomstoggle arrow icon

Amanita phalloides (death cap mushroom)

Background [28]

Clinical features [28]

Clinical features and symptom onset vary depending on the amount ingested; features are primarily due to hepatotoxicity.

Diagnostics [4][28]

A. phalloides poisoning is a clinical diagnosis.

Management [4][28]

Follow the ABCDE approach for poisoning.

Although antidotes for A. phalloides poisoning are not FDA-approved, evidence supports administering silibinin, N-acetylcysteine, or penicillin G in consultation with poison control.

Disposition

Amanita muscaria (fly agaric mushroom)

Background [4][30]

Clinical features [4][30][31]

Despite its name, A. muscaria is not generally associated with a cholinergic toxidrome or anticholinergic toxidrome. [4][32][33]

Diagnostics [4]

Management [4][30]

Treatment with atropine and physostigmine is discouraged as the effects of A. muscaria on the parasympathetic nervous system can be mixed. [32][33]

Gyromitra spp. (false morels)

General principles [4][34]

Clinical features [4][34]

Diagnostics [4]

Gyromitra poisoning is a clinical diagnosis.

Management [2][4]

IV pyridoxine is often crucial to treat seizures, as gyromitrin poisoning can cause refractory status epilepticus due to pyridoxine deficiency. [4]

Disposition

  • Altered mental status and/or seizures: Admit to the ICU.
  • Asymptomatic or mild symptoms
    • Consider discharge for patients who are asymptomatic after 6–8 hours.
    • If symptoms develop or worsen, admit for continued monitoring and treatment.

Plantstoggle arrow icon

Atropa belladonna (belladonna or deadly nightshade)

General principles [4]

Clinical features [4]

A. belladonna poisoning primarily manifests as anticholinergic syndrome.

Features of anticholinergic syndrome can be remembered with: “Blind as a bat (cycloplegia and mydriasis), mad as a hatter (delirium and hallucinations), red as a beet (cutaneous vasodilation), hot as hell (hyperthermia), dry as a bone (anhidrosis and xerophthalmia), the bowel and bladder lose their tone (urinary retention and absent bowel sounds), and the heart runs alone (tachycardia).

Diagnostics [4]

A. belladonna poisoning is a clinical diagnosis.

Management [4]

Other plants

Rodenticidestoggle arrow icon

Rodenticides are a type of pesticide used to kill rodents (e.g., rats, mice); active ingredients vary. [36]

Strychnine [2][37][38]

Superwarfarins [4][39][40]

Other rodenticides

Referencestoggle arrow icon

  1. Walls R, Hockberger R, Gausche-Hill M, Erickson TB, Wilcox SR. Rosen's Emergency Medicine 10th edition- Concepts and Clinical Practice E-Book. Elsevier Health Sciences ; 2022
  2. Nelson LS, Howland M, Lewin NA, Smith SW, Goldfrank LR, Hoffman RS. Goldfrank's Toxicologic Emergencies, 11th edition. McGraw-Hill Education ; 2019
  3. Bertinelli A, Hamill J, Mahadevan M, Miles F. Serious injuries from dishwasher powder ingestions in small children. J Paediatr Child Health. 2006; 42 (3): p.129-133.doi: 10.1111/j.1440-1754.2006.00811.x . | Open in Read by QxMD
  4. Bonney AG, Mazor S, Goldman RD. Laundry detergent capsules and pediatric poisoning. Can Fam Physician. 2013; 59 (12): p.1295-6; e535-7.
  5. Day R, Bradberry S, Sandilands E, Thomas S, Thompson J, Vale J. Toxicity of traditional and soluble film automatic dishwashing tablets. Hum Exp Toxicol. 2019; 39 (4): p.433-439.doi: 10.1177/0960327119891767 . | Open in Read by QxMD
  6. Hall AH, Jacquemin D, Henny D, Mathieu L, Josset P, Meyer B. Corrosive substances ingestion: a review. Crit Rev Toxicol. 2019; 49 (8): p.637-669.doi: 10.1080/10408444.2019.1707773 . | Open in Read by QxMD
  7. Chirica M, Bonavina L, Kelly MD, Sarfati E, Cattan P. Caustic ingestion. Lancet. 2017; 389 (10083): p.2041-2052.doi: 10.1016/s0140-6736(16)30313-0 . | Open in Read by QxMD
  8. Kamboj A, Spiller HA, Casavant MJ, Kistamgari S, Chounthirath T, Smith GA. Household cleaning product-related ocular exposures reported to the United States poison control centres. Eye. 2019; 34 (9): p.1631-1639.doi: 10.1038/s41433-019-0691-9 . | Open in Read by QxMD
  9. Medical management guidelines for hydrogen cyanide. https://web.archive.org/web/20240925190859/https://wwwn.cdc.gov/TSP/MMG/MMGDetails.aspx?mmgid=1073&toxid=19. Updated: October 21, 2014. Accessed: September 25, 2024.
  10. Reade MC, Davies SR, Morley PT, Dennett J, Jacobs IC. Review article: Management of cyanide poisoning. Emerg Med Australas. 2012; 24 (3): p.225-238.doi: 10.1111/j.1742-6723.2012.01538.x . | Open in Read by QxMD
  11. Parker-Cote JL, Rizer J, Vakkalanka JP, Rege SV, Holstege CP. Challenges in the diagnosis of acute cyanide poisoning. Clin Toxicol. 2018; 56 (7): p.609-617.doi: 10.1080/15563650.2018.1435886 . | Open in Read by QxMD
  12. Hendry-Hofer TB, Ng PC, Witeof AE, et al. A Review on Ingested Cyanide: Risks, Clinical Presentation, Diagnostics, and Treatment Challenges. J Med Toxicol. 2018; 15 (2): p.128-133.doi: 10.1007/s13181-018-0688-y . | Open in Read by QxMD
  13. Sodium Nitrite. https://web.archive.org/web/20240610181925/https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/203922s001lbl.pdf. Updated: October 1, 2017. Accessed: June 10, 2024.
  14. Boley SP, Olives TD, Bangh SA, Fahrner S, Cole JB. Physostigmine is superior to non-antidote therapy in the management of antimuscarinic delirium: a prospective study from a regional poison center. Clin Toxicol. 2018; 57 (1): p.50-55.doi: 10.1080/15563650.2018.1485154 . | Open in Read by QxMD
  15. Günther T, Dasgupta P, Mann A, et al. Targeting multiple opioid receptors – improved analgesics with reduced side effects?. Br J Pharmacol. 2017; 175 (14): p.2857-2868.doi: 10.1111/bph.13809 . | Open in Read by QxMD
  16. Yee J, Kaide C. Emergency Reversal of Anticoagulation. West J Emerg Med. 2019; 20 (5): p.770-783.doi: 10.5811/westjem.2018.5.38235 . | Open in Read by QxMD
  17. McBride L, Wang J, Ho P, Langsford D. Dabigatran Toxicity in Acute Kidney Injury: Hemodialysis and Idarucizumab Required. Kidney Int Rep. 2019; 4 (3): p.500-504.doi: 10.1016/j.ekir.2018.11.015 . | Open in Read by QxMD
  18. Oduah E, Linhardt R, Sharfstein S. Heparin: Past, Present, and Future. Pharmaceuticals. 2016; 9 (3): p.38.doi: 10.3390/ph9030038 . | Open in Read by QxMD
  19. Yaghi S, Willey JZ, Cucchiara B, et al. Treatment and Outcome of Hemorrhagic Transformation After Intravenous Alteplase in Acute Ischemic Stroke: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2017; 48 (12).doi: 10.1161/str.0000000000000152 . | Open in Read by QxMD
  20. Thanacoody HKR, Thomas SHL. Tricyclic Antidepressant Poisoning. Toxicol Rev. 2005; 24 (3): p.205-214.doi: 10.2165/00139709-200524030-00013 . | Open in Read by QxMD
  21. Kraut JA, Mullins ME. Toxic Alcohols. N Engl J Med. 2018; 378 (3): p.270-280.doi: 10.1056/nejmra1615295 . | Open in Read by QxMD
  22. Arsenic Toxicity - How Should Patients Overexposed to Arsenic Be Treated and Managed?. https://www.atsdr.cdc.gov/csem/csem.asp?csem=1&po=13. Updated: January 15, 2010. Accessed: January 9, 2018.
  23. Arsenic Toxicity - Clinical Assessment. https://www.atsdr.cdc.gov/csem/csem.asp?csem=1&po=12. Updated: January 15, 2010. Accessed: January 9, 2018.
  24. Ratnaike RN. Acute and chronic arsenic toxicity.. Postgrad Med J. 2003; 79 (933): p.391-6.
  25. Pearce JMS. Burton’s line in lead poisoning. Eur Neurol. 2006; 57 (2): p.118-119.doi: 10.1159/000098100 . | Open in Read by QxMD
  26. Rose JJ, Wang L, Xu Q, et al. Carbon Monoxide Poisoning: Pathogenesis, Management, and Future Directions of Therapy. Am J Respir Crit Care Med. 2017; 195 (5): p.596-606.doi: 10.1164/rccm.201606-1275ci . | Open in Read by QxMD
  27. Cefalu JN, Joshi TV, Spalitta MJ, et al. Methemoglobinemia in the Operating Room and Intensive Care Unit: Early Recognition, Pathophysiology, and Management. Adv Ther. 2020; 37 (5): p.1714-1723.doi: 10.1007/s12325-020-01282-5 . | Open in Read by QxMD
  28. Garcia J, Costa VM, Carvalho A, et al. Amanita phalloides poisoning: Mechanisms of toxicity and treatment. Food Chem Toxicol. 2015; 86: p.41-55.doi: 10.1016/j.fct.2015.09.008 . | Open in Read by QxMD
  29. Shingina A, Mukhtar N, Wakim-Fleming J, et al. Acute Liver Failure Guidelines. Am J Gastroenterol. 2023; 118 (7): p.1128-1153.doi: 10.14309/ajg.0000000000002340 . | Open in Read by QxMD
  30. Joanne Taylor, Stacy Holzbauer, Danushka Wanduragala, Alexander Ivaskovic, Ron Spinosa, Kirk Smith, Justin Corcoran, Ashley Jensen. Notes from the Field: Acute Intoxications from Consumption of Amanita muscaria Mushrooms — Minnesota, 2018. MMWR Morb Mortal Wkly Rep. 2019; 68 (21): p.483-484.doi: 10.15585/mmwr.mm6821a4 . | Open in Read by QxMD
  31. Moss MJ, Hendrickson RG. Toxicity of muscimol and ibotenic acid containing mushrooms reported to a regional poison control center from 2002–2016. Clin Toxicol. 2018; 57 (2): p.99-103.doi: 10.1080/15563650.2018.1497169 . | Open in Read by QxMD
  32. Maung AC, Hennessey M, Kadiyala R. Accidental colourful mushroom poisoning – delirium, delusions and dreams. Clin Med (Northfield Il). 2023; 23 (4): p.417-419.doi: 10.7861/clinmed.2023-0103 . | Open in Read by QxMD
  33. Rampolli FI, Kamler P, Carnevale Carlino C, Bedussi F. The Deceptive Mushroom: Accidental Amanita muscaria Poisoning. Eur J Case Rep Intern Med. 2021; 8 (3): p.002212.doi: 10.12890/2021_002212 . | Open in Read by QxMD
  34. Lagrange E, Vernoux JP. Warning on False or True Morels and Button Mushrooms with Potential Toxicity Linked to Hydrazinic Toxins: An Update. Toxins. 2020; 12 (8): p.482.doi: 10.3390/toxins12080482 . | Open in Read by QxMD
  35. Leathem AM, Dorran TJ. Poisoning due to raw Gyromitra esculenta (false morels) west of the Rockies. CJEM. 2007; 9 (02): p.127-130.doi: 10.1017/s1481803500014937 . | Open in Read by QxMD
  36. Rodenticides. https://web.archive.org/web/20240614192507/http://npic.orst.edu/factsheets/rodenticides.html. Updated: March 1, 2016. Accessed: June 14, 2024.
  37. Wood DM, Webster E, Martinez D, Dargan PI, Jones AL. Case report: Survival after deliberate strychnine self-poisoning, with toxicokinetic data. Crit Care. 2002; 6 (5).doi: 10.1186/cc1549 . | Open in Read by QxMD
  38. Smith BA. Strychnine poisoning. J Emerg Med. 1990; 8 (3): p.321-325.doi: 10.1016/0736-4679(90)90013-l . | Open in Read by QxMD
  39. Caravati EM, Erdman AR, Scharman EJ, et al. Long-acting anticoagulant rodenticide poisoning: An evidence-based consensus guideline for out-of-hospital management. Clin Toxicol. 2007; 45 (1): p.1-22.doi: 10.1080/15563650600795487 . | Open in Read by QxMD
  40. Chong YK, Mai TWL. Superwarfarin (Long-Acting Anti-coagulant Rodenticides) Poisoning: from Pathophysiology to Laboratory-Guided Clinical Management. Clin Biochem Rev. 2019; 40 (4): p.175-185.doi: 10.33176/aacb-19-00029 . | Open in Read by QxMD
  41. Ralston NV, Raymond LJ.. Dietary selenium's protective effects against methylmercury toxicity.. Toxicology. 2010.
  42. Lisa M. Gaetke, Hannah S. Chow-Johnson, and Ching K. Chow. Copper: Toxicological relevance and mechanisms. Archives of Toxicology. 2015.
  43. Umair M, Javed I, Rehman M, Madni A, Javeed A, Ghafoor A, Ashraf M.. Nanotoxicity of Inert Materials: The Case of Gold, Silver and Iron.. Journal of Pharmacy and Pharmaceutical Sciences. 2016.
  44. Lawson-Smith P, Jansen EC, Hyldegaard O. Cyanide intoxication as part of smoke inhalation - a review on diagnosis and treatment from the emergency perspective. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine. 2011; 19 (1): p.14.doi: 10.1186/1757-7241-19-14 . | Open in Read by QxMD
  45. Vanden Hoek TL, Morrison LJ, Shuster M, et al. Part 12: Cardiac Arrest in Special Situations: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2010; 122 (18_suppl_3): p.S829-S861.doi: 10.1161/circulationaha.110.971069 . | Open in Read by QxMD
  46. ISBI Practice Guidelines Committee, Ahuja RB, Gibran N, et al. ISBI Practice Guidelines for Burn Care. Burns. 2016; 42 (5): p.953-1021.doi: 10.1016/j.burns.2016.05.013 . | Open in Read by QxMD
Sign up and get unlimited access.
disclaimer Evidence-based content, created and peer-reviewed by physicians. Read the disclaimer